Copyright
©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 571-583
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.571
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.571
Junquera et al[2] | Fernandez-Lopez et al[6] | Jackson et al[5] | Allende et al[4] | Curran et al[3] | ||||||
TFSA (n = 2978) | TRSA (n = 928) | TFSA (n = 194) | TRSA (n = 217) | TFSA (n = 64) | TRSA (n = 135) | TFSA (n = 335) | TRSA (n = 127) | TFSA (n = 41) | TRSA (n = 46) | |
Baseline characteristics of patients | ||||||||||
Age | 81 ± 4 | 81 ± 8 | 83 ± 7 | 82 ± 6 | 82 ± 6 | 82 ± 7 | 79 ± 8 | 80 ± 9 | 80 ± 10 | 80 ± 5 |
%Male | 52.60% | 53.20% | 44.80% | 53.50% | 57.00% | 43.00% | 45.00% | 61.00% | 31.70% | 52.20% |
Baseline comorbidities | ||||||||||
Diabetes | 26.90% | 27.00% | 31.40% | 24.40% | 20.00% | 20.00% | 35.00% | 31.00% | 30.00% | 26.10% |
HTN | - | - | 56.70% | 55.30% | - | - | 88.00% | 84.00% | 92.50% | 80.40% |
CAD | 51.20% | 50.30% | - | - | 53.00% | 52.60% | 67.00% | 63.00% | - | - |
Previous CABG | 19.80% | 19.60% | 4.10% | 6.00% | 20.00% | 19.30% | 39.00% | 33.00% | 17.10% | 17.40% |
AFib | 33.50% | 34.70% | 27.80% | 33.60% | 25.00% | 25.00% | 17.00% | 20.00% | - | - |
PVD | 16.30% | 19.20% | 13.40% | 14.30% | 18.00% | 26.70% | 40.00% | 24.00% | - | - |
Prior CVA | - | - | 10.30% | 10.60% | 17.00% | 16.30% | 19.00% | 16.00% | - | - |
eGFR < 60 mL/min/1.73 m2 | 67.60% | 69.40% | - | - | - | - | 57.00% | 51.00% | - | - |
COPD/Pul disease | 21.30% | 20.90% | 11.90% | 13.40% | 25.00% | 25.90% | 29.00% | 25.00% | 20.00% | 13.00% |
STS-PROM score | 4.5 | 4.7 | 5.0 ± 3.0 | 4.8 ± 3.6 | - | - | 7.1 ± 4.5 | 7.2 ± 5.0 | 9.0 ± 7.8 | 7.2 ± 7.5 |
Valve type | ||||||||||
Balloon-expandable | 60.00% | 63.50% | NA | NA | NA | NA | 96.00% | 88.00% | NA | NA |
Self-expandable | 40.00% | 36.50% | NA | NA | NA | NA | 3.00% | 10.00% | NA | NA |
1° Access | ||||||||||
TFPA | 88.50% | 89.90% | 100% | 100% | 100% | 85.20% | 30.80% | 93.00% | 100% | 100% |
Non-TFPA | 11.50% | 10.10% | 0 | 0 | 0 | 14.80% | 69.20% | 7.00% | 0 | 0 |
Transapical | 9.10% | 3.70% | 58.20% | 6.00% | ||||||
Transaortic | 1.90% | 8.80% | 10.70% | 1.00% | ||||||
Subclavian | 1.50% | 2.20% | 0.30% | 0 | ||||||
Transcarotid | 4.06% | 0 | 0 | 0 | ||||||
Transcaval | 0.12% | 0 | 0 | 0 |
- Citation: Radhakrishnan SL, Ho KKL. Transradial vs transfemoral secondary access outcomes in transcatheter aortic valve implantation: A systematic review and meta-analysis. World J Cardiol 2020; 12(11): 571-583
- URL: https://www.wjgnet.com/1949-8462/full/v12/i11/571.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i11.571